Sysmex Cuts Full-Year Forecast on Weaker China Demand and FX Shift

Sysmex ( (JP:6869) ) just unveiled an announcement.

Sysmex Corporation has lowered its full-year consolidated forecast for the fiscal year ending March 31, 2026, citing weaker-than-expected sales in China and updated foreign exchange assumptions. The company now projects net sales of ¥500 billion, operating profit of ¥62 billion and profit attributable to owners of the parent of ¥41 billion, all below both its previous forecast and the prior year’s results.

The revisions imply a 2 percent decline in sales and a sharper drop in profitability, with operating profit expected to fall 18.4 percent versus the earlier outlook, reflecting demand softness in a key market despite ongoing efforts to improve profitability and control SG&A expenses. Sysmex has also adjusted its assumed full-year average exchange rates, incorporating a weaker yen against the U.S. dollar, euro and Chinese yuan, underscoring the company’s sensitivity to macroeconomic and regional market conditions.

The most recent analyst rating on (JP:6869) stock is a Buy with a Yen1642.00 price target. To see the full list of analyst forecasts on Sysmex stock, see the JP:6869 Stock Forecast page.

More about Sysmex

Sysmex Corporation, based in Kobe, Japan, operates in the medical diagnostics and laboratory equipment industry, providing hematology analyzers and related in vitro diagnostic systems to hospitals and clinical laboratories worldwide. The company focuses on expanding its global presence, with a significant market exposure in regions such as China, where demand trends and currency fluctuations materially influence its financial performance.

Average Trading Volume: 3,354,568

Technical Sentiment Signal: Sell

Current Market Cap: Yen948.2B

Learn more about 6869 stock on TipRanks’ Stock Analysis page.